Next generation sequencing of Hepatitis C virus to detect drug resistance mutations

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1055966

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Hepatitis C is the leading cause of liver cancer and liver failure requiring transplantation in Australia. New antiviral drugs set to revolutionise hepatitis C treatment by substantially improving cure rates could be challenged by the development of resistance mutations, which would make these drugs less effective. We aim to develop a practical test to be used routinely to guide clinicians in choosing appropriate anti-viral drugs for their patients.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2014

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $39,497.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiviral therapy | bioinformatics | clinical microbiology | genetic epidemiology | genetic linkage | hepatitis C virus | outcome assessment | prevalence | resistance | sequence analysis

Related Links